150 related articles for article (PubMed ID: 29902495)
21. Involvement of the gonococcal MtrE protein in the resistance of Neisseria gonorrhoeae to toxic hydrophobic agents.
Delahay RM; Robertson BD; Balthazar JT; Shafer WM; Ison CA
Microbiology (Reading); 1997 Jul; 143 ( Pt 7)():2127-2133. PubMed ID: 9245802
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of immune responses by co-administration of bacterial ghosts-mediated Neisseria gonorrhoeae DNA vaccines.
Jiao H; Yang H; Zheng W; Zhang Q; Zhao D; Li G
J Appl Microbiol; 2021 May; 130(5):1770-1777. PubMed ID: 32770820
[TBL] [Abstract][Full Text] [Related]
23. [Gonococcal surface antigens and their significance for serotyping and vaccines].
Kohl PK; Meyer TF; Petzoldt D
Hautarzt; 1985 Jun; 36(6):320-5. PubMed ID: 2862130
[TBL] [Abstract][Full Text] [Related]
24. Regulation of the MtrC-MtrD-MtrE efflux-pump system modulates the in vivo fitness of Neisseria gonorrhoeae.
Warner DM; Folster JP; Shafer WM; Jerse AE
J Infect Dis; 2007 Dec; 196(12):1804-12. PubMed ID: 18190261
[TBL] [Abstract][Full Text] [Related]
25. Structure-based design of broadly protective group a streptococcal M protein-based vaccines.
Dale JB; Smeesters PR; Courtney HS; Penfound TA; Hohn CM; Smith JC; Baudry JY
Vaccine; 2017 Jan; 35(1):19-26. PubMed ID: 27890396
[TBL] [Abstract][Full Text] [Related]
26. Expression of AniA, the major anaerobically induced outer membrane protein of Neisseria gonorrhoeae, provides protection against killing by normal human sera.
Cardinale JA; Clark VL
Infect Immun; 2000 Jul; 68(7):4368-9. PubMed ID: 10858263
[TBL] [Abstract][Full Text] [Related]
27. Complement-Dependent Serum Bactericidal Assays for Neisseria gonorrhoeae.
Gulati S; Rice PA; Ram S
Methods Mol Biol; 2019; 1997():267-280. PubMed ID: 31119629
[TBL] [Abstract][Full Text] [Related]
28. Idiotype and anti-anti-idiotype antibodies to Neisseria gonorrhoeae lipooligosaccharides with bactericidal activity but no cross-reactivity with red blood cell antigens.
Brossay L; Paradis G; Pépin A; Mourad W; Coté L; Hébert J
J Immunol; 1993 Jul; 151(1):234-43. PubMed ID: 7686935
[TBL] [Abstract][Full Text] [Related]
29. Topology of outer membrane porins in pathogenic Neisseria spp.
van der Ley P; Heckels JE; Virji M; Hoogerhout P; Poolman JT
Infect Immun; 1991 Sep; 59(9):2963-71. PubMed ID: 1652557
[TBL] [Abstract][Full Text] [Related]
30. The role of anti-NHba antibody in bactericidal activity elicited by the meningococcal serogroup B vaccine, MenB-4C.
Partridge E; Lujan E; Giuntini S; Vu DM; Granoff DM
Vaccine; 2017 Jul; 35(33):4236-4244. PubMed ID: 28651840
[TBL] [Abstract][Full Text] [Related]
31. Proteomics-driven Antigen Discovery for Development of Vaccines Against Gonorrhea.
Zielke RA; Wierzbicki IH; Baarda BI; Gafken PR; Soge OO; Holmes KK; Jerse AE; Unemo M; Sikora AE
Mol Cell Proteomics; 2016 Jul; 15(7):2338-55. PubMed ID: 27141096
[TBL] [Abstract][Full Text] [Related]
32. Evidence for the assembly of a bacterial tripartite multidrug pump with a stoichiometry of 3:6:3.
Janganan TK; Bavro VN; Zhang L; Matak-Vinkovic D; Barrera NP; Venien-Bryan C; Robinson CV; Borges-Walmsley MI; Walmsley AR
J Biol Chem; 2011 Jul; 286(30):26900-12. PubMed ID: 21610073
[TBL] [Abstract][Full Text] [Related]
33. Opening of the outer membrane protein channel in tripartite efflux pumps is induced by interaction with the membrane fusion partner.
Janganan TK; Zhang L; Bavro VN; Matak-Vinkovic D; Barrera NP; Burton MF; Steel PG; Robinson CV; Borges-Walmsley MI; Walmsley AR
J Biol Chem; 2011 Feb; 286(7):5484-93. PubMed ID: 21115481
[TBL] [Abstract][Full Text] [Related]
34. Immunoglobulin G antibodies directed against protein III block killing of serum-resistant Neisseria gonorrhoeae by immune serum.
Rice PA; Vayo HE; Tam MR; Blake MS
J Exp Med; 1986 Nov; 164(5):1735-48. PubMed ID: 3095479
[TBL] [Abstract][Full Text] [Related]
35. A putative amino acid ABC transporter substrate-binding protein, NMB1612, from Neisseria meningitidis, induces murine bactericidal antibodies against meningococci expressing heterologous NMB1612 proteins.
Hung MC; Humbert MV; Laver JR; Phillips R; Heckels JE; Christodoulides M
Vaccine; 2015 Aug; 33(36):4486-94. PubMed ID: 26207592
[TBL] [Abstract][Full Text] [Related]
36. MetQ of Neisseria gonorrhoeae Is a Surface-Expressed Antigen That Elicits Bactericidal and Functional Blocking Antibodies.
Semchenko EA; Day CJ; Seib KL
Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27895130
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of novel Streptococcus pyogenes vaccine candidates incorporating multiple conserved sequences from the C-repeat region of the M-protein.
Bauer MJ; Georgousakis MM; Vu T; Henningham A; Hofmann A; Rettel M; Hafner LM; Sriprakash KS; McMillan DJ
Vaccine; 2012 Mar; 30(12):2197-205. PubMed ID: 22265945
[TBL] [Abstract][Full Text] [Related]
38. Outer membrane protein (OMP) based vaccine for Neisseria meningitidis serogroup B.
Pillai S; Howell A; Alexander K; Bentley BE; Jiang HQ; Ambrose K; Zhu D; Zlotnick G
Vaccine; 2005 Mar; 23(17-18):2206-9. PubMed ID: 15755596
[TBL] [Abstract][Full Text] [Related]
39. Functional characterization of antibodies against Neisseria gonorrhoeae opacity protein loops.
Cole JG; Jerse AE
PLoS One; 2009 Dec; 4(12):e8108. PubMed ID: 19956622
[TBL] [Abstract][Full Text] [Related]
40. The primary sequence and antigenic structure of gonococcal pilin: approaches towards a gonococcal vaccine.
Rothbard JB; Schoolnik GK
Adv Exp Med Biol; 1985; 185():247-73. PubMed ID: 2416202
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
